HRP20220979T8 - Sastavi za liječenje amiloidoze - Google Patents
Sastavi za liječenje amiloidoze Download PDFInfo
- Publication number
- HRP20220979T8 HRP20220979T8 HRP20220979TT HRP20220979T HRP20220979T8 HR P20220979 T8 HRP20220979 T8 HR P20220979T8 HR P20220979T T HRP20220979T T HR P20220979TT HR P20220979 T HRP20220979 T HR P20220979T HR P20220979 T8 HRP20220979 T8 HR P20220979T8
- Authority
- HR
- Croatia
- Prior art keywords
- compositions
- treating amyloidosis
- amyloidosis
- treating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662357151P | 2016-06-30 | 2016-06-30 | |
EP17740200.5A EP3478713B1 (en) | 2016-06-30 | 2017-06-30 | Compositions for treating amyloidosis |
PCT/US2017/040289 WO2018005967A1 (en) | 2016-06-30 | 2017-06-30 | Compositions for treating amyloidosis |
Publications (2)
Publication Number | Publication Date |
---|---|
HRP20220979T1 HRP20220979T1 (hr) | 2022-11-11 |
HRP20220979T8 true HRP20220979T8 (hr) | 2023-02-03 |
Family
ID=59351103
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HRP20220979TT HRP20220979T8 (hr) | 2016-06-30 | 2017-06-30 | Sastavi za liječenje amiloidoze |
Country Status (14)
Country | Link |
---|---|
US (2) | US20190169280A1 (hr) |
EP (1) | EP3478713B1 (hr) |
JP (2) | JP2019519584A (hr) |
DK (1) | DK3478713T3 (hr) |
ES (1) | ES2914781T3 (hr) |
HR (1) | HRP20220979T8 (hr) |
HU (1) | HUE059400T2 (hr) |
LT (1) | LT3478713T (hr) |
MA (1) | MA45552A (hr) |
PL (1) | PL3478713T3 (hr) |
PT (1) | PT3478713T (hr) |
RS (1) | RS63446B1 (hr) |
SI (1) | SI3478713T1 (hr) |
WO (1) | WO2018005967A1 (hr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2020009920A (es) * | 2018-03-23 | 2020-12-10 | Prothena Biosciences Ltd | Tratamiento y profilaxis de amiloidosis. |
CN113924099A (zh) * | 2019-02-12 | 2022-01-11 | 普罗塞纳生物科学有限公司 | 针对免疫球蛋白轻链的单克隆抗体与抗体产生细胞和其他免疫细胞上的cd38细胞膜分子的组合治疗al淀粉样变性 |
JP2022522889A (ja) * | 2019-03-05 | 2022-04-20 | プロシーナ バイオサイエンシーズ リミテッド | Alアミロイドーシスを処置する方法 |
WO2021041884A1 (en) * | 2019-08-30 | 2021-03-04 | Alnylam Pharmaceuticals, Inc. | Neurofilament light chain (nfl) as a biomarker for transthyretin amyloidosis polyneuropathy |
CA3187944A1 (en) * | 2020-06-22 | 2021-12-30 | Ngm Biopharmaceuticals, Inc. | Lair-1-binding agents and methods of use thereof |
TW202332465A (zh) * | 2021-01-29 | 2023-08-16 | 愛爾蘭商普羅希那生物科學有限公司 | 治療al類澱粉變性症之方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1355919B1 (en) | 2000-12-12 | 2010-11-24 | MedImmune, LLC | Molecules with extended half-lives, compositions and uses thereof |
AU2008345022B2 (en) | 2007-12-28 | 2014-11-06 | Prothena Biosciences Limited | Treatment and prophylaxis of amyloidosis |
KR102196009B1 (ko) | 2011-10-25 | 2021-01-04 | 프로테나 바이오사이언시즈 리미티드 | 항체 제형 및 방법 |
-
2017
- 2017-06-30 PT PT177402005T patent/PT3478713T/pt unknown
- 2017-06-30 MA MA045552A patent/MA45552A/fr unknown
- 2017-06-30 SI SI201731146T patent/SI3478713T1/sl unknown
- 2017-06-30 DK DK17740200.5T patent/DK3478713T3/da active
- 2017-06-30 JP JP2018568771A patent/JP2019519584A/ja not_active Withdrawn
- 2017-06-30 RS RS20220716A patent/RS63446B1/sr unknown
- 2017-06-30 PL PL17740200.5T patent/PL3478713T3/pl unknown
- 2017-06-30 EP EP17740200.5A patent/EP3478713B1/en active Active
- 2017-06-30 HR HRP20220979TT patent/HRP20220979T8/hr unknown
- 2017-06-30 US US16/314,143 patent/US20190169280A1/en not_active Abandoned
- 2017-06-30 ES ES17740200T patent/ES2914781T3/es active Active
- 2017-06-30 WO PCT/US2017/040289 patent/WO2018005967A1/en active Search and Examination
- 2017-06-30 LT LTEPPCT/US2017/040289T patent/LT3478713T/lt unknown
- 2017-06-30 HU HUE17740200A patent/HUE059400T2/hu unknown
-
2020
- 2020-09-25 US US17/032,884 patent/US20210079078A1/en not_active Abandoned
-
2022
- 2022-07-01 JP JP2022106974A patent/JP2022121658A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
PL3478713T3 (pl) | 2022-10-10 |
SI3478713T1 (sl) | 2022-06-30 |
EP3478713B1 (en) | 2022-05-11 |
HUE059400T2 (hu) | 2022-11-28 |
US20190169280A1 (en) | 2019-06-06 |
MA45552A (fr) | 2019-05-08 |
HRP20220979T1 (hr) | 2022-11-11 |
ES2914781T3 (es) | 2022-06-16 |
WO2018005967A1 (en) | 2018-01-04 |
RS63446B1 (sr) | 2022-08-31 |
DK3478713T3 (da) | 2022-06-20 |
LT3478713T (lt) | 2022-06-10 |
JP2022121658A (ja) | 2022-08-19 |
PT3478713T (pt) | 2022-05-27 |
JP2019519584A (ja) | 2019-07-11 |
EP3478713A1 (en) | 2019-05-08 |
US20210079078A1 (en) | 2021-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL261792B (en) | Preparations | |
IL260933A (en) | Preparations containing tocorsol or its analogues | |
GB201715639D0 (en) | Compositions for wound treatment | |
HUE059694T2 (hu) | Készítmény rák kezelésére | |
GB201610156D0 (en) | Cliptac compositions | |
SI3478713T1 (sl) | Sestavki za zdravljenje amiloidoze | |
GB201600075D0 (en) | Immunogenci composition | |
IL265255A (en) | Dementia treatment preparations | |
GB201614799D0 (en) | Compositions | |
EP3443034C0 (en) | COMPOSITION | |
GB201622161D0 (en) | Compositions | |
EP3413873C0 (en) | NEW COMPOSITIONS | |
GB201610628D0 (en) | New compositions | |
HUE062406T2 (hu) | Készítmények szemészeti állapotok kezelésére | |
IL246919B (en) | New preparations for the treatment of mechanical nerve injuries | |
GB201602658D0 (en) | Compositions | |
IL268715A (en) | Preparations for the treatment of acne | |
GB201614230D0 (en) | Compositions | |
GB201611960D0 (en) | Compositions | |
GB201611851D0 (en) | Compositions | |
GB201510658D0 (en) | Compositions for wound treatment | |
GB201602656D0 (en) | Compositions | |
GB201604900D0 (en) | Composition | |
GB201604899D0 (en) | Composition | |
GB201604341D0 (en) | Composition |